These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29955130)

  • 1. LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting.
    Thurner L; Hartmann S; Fadle N; Kemele M; Bock T; Bewarder M; Regitz E; Neumann F; Nimmesgern A; von Müller L; Pott C; Kim YJ; Bohle RM; Wasik M; Schuster SJ; Hansmann ML; Preuss KD; Pfreundschuh M
    Leukemia; 2019 Jan; 33(1):148-158. PubMed ID: 29955130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome.
    Thurner L; Fadle N; Bittenbring JT; Regitz E; Schuck R; Cetin O; Stuhr A; Rixecker T; Murawski N; Poeschel V; Kaddu-Mulindwa D; Preuss KD; Stilgenbauer S; Hermine O; Kluin-Nelemans HC; Hartmann S; Dreyling M; Pott C; Bewarder M; Hoster E
    Blood; 2021 Jun; 137(23):3251-3258. PubMed ID: 33513604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells.
    Zwick C; Fadle N; Regitz E; Kemele M; Stilgenbauer S; Bühler A; Pfreundschuh M; Preuss KD
    Blood; 2013 Jun; 121(23):4708-17. PubMed ID: 23580660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells.
    Bewarder M; Kiefer M; Will H; Olesch K; Moelle C; Stilgenbauer S; Christofyllakis K; Kaddu-Mulindwa D; Bittenbring JT; Fadle N; Regitz E; Kaschek L; Hoth M; Neumann F; Preuss KD; Pfreundschuh M; Thurner L
    Hemasphere; 2021 Aug; 5(8):e620. PubMed ID: 34263144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of B cell antigen receptors in mantle cell lymphoma.
    Fichtner M; Dreyling M; Binder M; Trepel M
    J Hematol Oncol; 2017 Oct; 10(1):164. PubMed ID: 29041946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Specific B-Cell Receptor Antigens in Lymphomagenesis.
    Thurner L; Hartmann S; Neumann F; Hoth M; Stilgenbauer S; Küppers R; Preuss KD; Bewarder M
    Front Oncol; 2020; 10():604685. PubMed ID: 33363034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens.
    Young RM; Wu T; Schmitz R; Dawood M; Xiao W; Phelan JD; Xu W; Menard L; Meffre E; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Staudt LM
    Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13447-54. PubMed ID: 26483459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas.
    Elbert M; Neumann F; Kiefer M; Christofyllakis K; Balensiefer B; Kos I; Carbon G; Kaddu-Mulindwa D; Bittenbring JT; Fadle N; Regitz E; Fend F; Bonzheim I; Thurner L; Bewarder M
    Sci Rep; 2024 Apr; 14(1):9571. PubMed ID: 38671086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma.
    Thurner L; Hartmann S; Fadle N; Regitz E; Kemele M; Kim YJ; Bohle RM; Nimmesgern A; von Müller L; Kempf VAJ; Weniger MA; Neumann F; Schneider N; Vornanen M; Sundström C; de Leval L; Engert A; Eichenauer DA; Küppers R; Preuss KD; Hansmann ML; Pfreundschuh M
    Nat Commun; 2020 May; 11(1):2465. PubMed ID: 32424289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant high expression of Toll-like receptor (TLR) and B-cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma.
    Akhter A; Street L; Ghosh S; Burns BF; Elyamany G; Shabani-Rad MT; Stewart DA; Mansoor A
    Hematol Oncol; 2017 Mar; 35(1):79-86. PubMed ID: 26354285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX11 augments BCR signaling to drive MCL-like tumor development.
    Kuo PY; Jatiani SS; Rahman AH; Edwards D; Jiang Z; Ahr K; Perumal D; Leshchenko VV; Brody J; Shaknovich R; Ye BH; Parekh S
    Blood; 2018 May; 131(20):2247-2255. PubMed ID: 29615403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen selection in B-cell lymphomas--tracing the evidence.
    Sutton LA; Agathangelidis A; Belessi C; Darzentas N; Davi F; Ghia P; Rosenquist R; Stamatopoulos K
    Semin Cancer Biol; 2013 Dec; 23(6):399-409. PubMed ID: 23932942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydophila psittaci-negative ocular adnexal marginal zone lymphomas express self polyreactive B-cell receptors.
    Zhu D; Bhatt S; Lu X; Guo F; Veelken H; Hsu DK; Liu FT; Alvarez Cubela S; Kunkalla K; Vega F; Chapman-Fredricks JR; Lossos IS
    Leukemia; 2015 Jul; 29(7):1587-99. PubMed ID: 25676418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma.
    Thurner L; Hartmann S; Bewarder M; Fadle N; Regitz E; Schormann C; Quiroga N; Kemele M; Klapper W; Rosenwald A; Trümper L; Bohle RM; Nimmesgern A; Körbel C; Lascke MW; Menger MD; Barth S; Kubuschok B; Mottok A; Kaddu-Mulindwa D; Hansmann ML; Pöschel V; Held G; Murawski N; Stilgenbauer S; Neumann F; Preuss KD; Pfreundschuh M
    Haematologica; 2021 Aug; 106(8):2224-2232. PubMed ID: 32675228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen.
    Cha SC; Qin H; Kannan S; Rawal S; Watkins LS; Baio FE; Wu W; Ong J; Wei J; Kwak B; Kim S; Popescu MS; Paick DS; Kim K; Luong A; Davis RE; Schroeder HW; Kwak LW; Neelapu SS
    J Immunol; 2013 May; 190(9):4887-98. PubMed ID: 23536634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling.
    Pighi C; Gu TL; Dalai I; Barbi S; Parolini C; Bertolaso A; Pedron S; Parisi A; Ren J; Cecconi D; Chilosi M; Menestrina F; Zamò A
    Cell Oncol (Dordr); 2011 Apr; 34(2):141-53. PubMed ID: 21394647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells.
    Köhler F; Hug E; Eschbach C; Meixlsperger S; Hobeika E; Kofer J; Wardemann H; Jumaa H
    Immunity; 2008 Dec; 29(6):912-21. PubMed ID: 19084434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens.
    Chiorazzi N; Hatzi K; Albesiano E
    Ann N Y Acad Sci; 2005 Dec; 1062():1-12. PubMed ID: 16461783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive selection of B cells expressing low densities of self-reactive BCRs.
    Gaudin E; Hao Y; Rosado MM; Chaby R; Girard R; Freitas AA
    J Exp Med; 2004 Mar; 199(6):843-53. PubMed ID: 15024048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting B cell receptor signalling in cancer: preclinical and clinical advances.
    Burger JA; Wiestner A
    Nat Rev Cancer; 2018 Mar; 18(3):148-167. PubMed ID: 29348577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.